On the recordMay 27, 2026
We filed this brief because the Biden FDA’s approval of chemical abortion drugs plainly puts young women and their unborn children at risk.
Source
cassidy.senate.govEditor's note · Context
Speaker Johnson explains the rationale behind the amicus brief.
Share & report
More from Mike Johnson
Dec 8, 2025
Mr. Johnson has clearly and repeatedly stated he is supportive of access to I.V.F. when sufficient pro-life protections are in place.
Other voices in this conversation
